Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series Ltd: World’s leading Event Organizer

Back

Joseph Birkett

Joseph Birkett

Director
Crest Pharma Ltd
UK

Biography

Joseph Birkett is currently working as a Director and Owner in Crest Pharma Ltd. He has Very experienced drug developer with over 15 years experience across all phases (I-IV and post-marketing). He has extensive experience in haematology (NHL/CLL) and solid tumours. Experienced in the clinical development of Tyrosine Kinase inhibitors (Global clinical lead for Btk ONO-4059), Monoclonal antibodies (lead clinical scientist for pivotal Phase I/II GA101/Obinutuzumab studies), ASOs (Survivin and Eif4e), DNA repair. His experience includes in working with patient advocacy groups to enhance patient and doctor understanding of new and existing therapy options.

Research Interest

Pre-clinical studies, new therapies for the treatment of cancer, drug development process.